ATLASATLAS fair value
ATLAS has no fair value for this stock today.
Avita Medical (AVH.AU)
Avita Medical share price today, ATLAS forecast and fair value
Healthcare · Medical Devices · Australian Securities Exchange · Australia
A$4.25▼ -1.16%
Prices as of Oct 27, 2026 · AUD
Chance of rising in 1 month
45%
that it ends higher than today in 21 sessions
0%coin flip 50%100%
This is just the summary. See everything on Avita Medical in ATLAS
ATLAS's own quantitative analysis, all in one place.
- Simulation and expected rangeThousands of simulated scenarios: how far the price could rise or fall.
- Officers and shareholdersWho runs the company and which funds hold its shares.
- Customer and supplier mapWho it does business with, from its own filings.
- ATLAS builds your portfolioAnswer a short test and get portfolios that fit you.
- AlertsWe let you know when something changes in your stocks.
See everything included
- Valuation and financialsFair value step by step, quarterly accounts and upcoming events.
- NewsThe latest on the company, in one place.
- Crisis simulatorHow your portfolio would do in a crash like 2008.
- Practice risk-free$10,000 in virtual money to invest at real prices.
- Global screenerSearch US stocks and stocks from 47 countries with filters.
On Avita Medical
- Simulation and expected rangeThousands of simulated scenarios: how far the price could rise or fall.
- Officers and shareholdersWho runs the company and which funds hold its shares.
- Customer and supplier mapWho it does business with, from its own filings.
- Valuation and financialsFair value step by step, quarterly accounts and upcoming events.
- NewsThe latest on the company, in one place.
And for you
- ATLAS builds your portfolioAnswer a short test and get portfolios that fit you.
- AlertsWe let you know when something changes in your stocks.
- Crisis simulatorHow your portfolio would do in a crash like 2008.
- Practice risk-free$10,000 in virtual money to invest at real prices.
- Global screenerSearch US stocks and stocks from 47 countries with filters.
Plans from €3.99 a month.
ATLAS's model gives Avita Medical a 45% chance of finishing higher a month from now (21 trading sessions) than today: close to a coin flip.
In half of the simulated outcomes the price ends between A$3.58 and A$4.81; in 9 out of 10, between A$2.75 and A$6.25. Estimated annual volatility is 90%.
Price, last 12 months (weekly close)
Key numbers
- Market cap
- A$566M
- Market cap (USD)
- $398M
- 52-week high
- A$4.42
- 52-week low
- A$1.00
- Revenue (12 months)
- $75.6M
- Gross margin
- 81.6%
- Operating margin
- -31.6%
- Net margin
- -57.0%
- Beta
- 1.99
What this means
ATLAS does not publish a fair value for AVH.AU right now, but it does show its odds of rising: close to a coin flip.
Over the last 52 weeks AVH.AU has traded between A$1.00 and A$4.42. Today it is 3.9% below that high and 325% above its low.
Its beta is 1.99: it tends to move more than the market, both up and down.
About the company
AVITA Medical, Inc., together with its subsidiaries, operates as a therapeutic acute wound care company in the United States, Japan, the European Union, Australia, and the United Kingdom.
Want to see everything about Avita Medical?
Get started →Plans from €3.99 a month.
Comparable companies
Other companies in the same line of business:
Frequently asked questions
What does Avita Medical do?
AVITA Medical, Inc., together with its subsidiaries, operates as a therapeutic acute wound care company in the United States, Japan, the European Union, Australia, and the United Kingdom.
What is the chance AVH.AU goes up next month?
45%: close to a coin flip. In half of the simulated outcomes, AVH.AU ends the month between A$3.58 and A$4.81.
How big is Avita Medical and what is its P/E ratio?
Avita Medical's market capitalization is A$566M. We do not show a P/E because it has no positive earnings to base one on.
How volatile is AVH.AU?
ATLAS estimates annual volatility at 90%. In a typical month, half of the outcomes end between A$3.58 and A$4.81.
Not investment advice. ATLAS estimates are produced by statistical models from public data; they can be wrong and past performance does not predict future results. Consider your own situation before investing. Disclaimer